Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

Fayoum University46 enrolled

Overview

The study will include patients with oral cancer and healthy controls of both sexes. Subjects having any systemic diseases or other types of cancer will be excluded. All subjects will be selected from Oral Medicine Department, Faculty of Dentistry, Al Ahram Canadian University and Fayoum University. Informed consent will be obtained from all subjects enrolled in this study after explanation of the whole procedure.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Oral Cancer Oral Squamous Cell Carcinoma

Interventions

ELISADIAGNOSTIC_TEST

quantitative determination of salivary SOX7 using an Enzyme Linked Immunosorbent assay (ELISA) kit based on the sandwich principle according to the manufacturer's protocol.

Eligibility

Sex: ALLMin age: 12 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients with oral cancer Exclusion Criteria: * any systemic diseases or other types of cancer will be excluded

Locations (1)

Fayoum University

Al Fayyum, Egypt

Outcomes

Primary Outcomes

salivary expression of SOX7

Time frame: 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.